Newsroom
To Get in Touch with DLC:
Media (@) Diabetes Leadership (DOT) org
Hot Topics
In The News
Diabetes Leadership Council Calls for Expanded Patient Choice in Diabetes Technologies to Improve Outcomes and Equity
DLC and DPAC Respond to Section 232 Investigation on Pharmaceuticals
Letter
DLC/DPAC Letter to HHS and NIH on the Importance of DPPOS Funding
Letter
DLC and DPAC are Disappointed in the CMS Decision Not to Extend Obesity Treatment Coverage to Medicare & Medicaid Beneficiaries
DLC and DPAC Statement Regarding Funding for the Diabetes Prevention Program
DLC Brief: Modernize Medicare Coverage for Equitable, Evidence-based Access to Diabetes Technologies
DLC Brief: Support Insulin Cost-Sharing Caps
DLC Brief: Increase Transparency and Accountability to Reduce Patient Out-of-Pocket Costs
DLC Brief: Type 1 Diabetes Screening
Letter
DLC and DPAC Statement on Medicaid Program Cuts
DLC and DPAC Joint Statement on Congress' End of Year Spending Package
DLC Brief: Addressing the Obesity Epidemic
Release
Statement on Lilly Diabetes Decision to Cut Insulin Costs
Release
MN lawmakers urged to act now
Release
DLC Advocates for Coverage of Life-Saving Technology
Release
DLC calls out KY legislature on failure to fund diabetes prevention
Report
Medicare payment rule changes may undermine diabetes care
Report
DLC Position on Non-Medical Switching
Statements and Letters
Fast Facts
Policy Recommendations to Improve U.S. Health Care
Patient costs for medicines, equipment and supplies should reflect all discounts and rebates negotiated or mandated across the supply chain, just like other health care products and services. National level rebate reform is a critical step to help patients afford their medicines and confront perverse financial incentives in the current system.
Download Our Consensus Statement